REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology
NCT ID: NCT05175937
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1104 participants
OBSERVATIONAL
2021-09-22
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arrhythmias Detection in a Real World Population
NCT02275637
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
NCT06324682
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure Patients
NCT05103267
Full Automaticity and Remote Follow-up
NCT01526629
Evaluation of the " Tele-follow-up " for the Follow-up of Implantable Defibrillators
NCT00598026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APP group
Patient wearing ICD with Bluetooth® technology and smartphone APP based remote monitoring
smartphone APP based remote monitoring
smartphone APP to monitor remotely patients implanted with ICD
Bedside transmitter group
Patient wearing ICD monitored remotely through a bedside transmitter
bedside transmitter based remote monitoring
bedside transmitter to monitor remotely patients implanted with ICD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smartphone APP based remote monitoring
smartphone APP to monitor remotely patients implanted with ICD
bedside transmitter based remote monitoring
bedside transmitter to monitor remotely patients implanted with ICD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years of age
* Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations
Exclusion Criteria
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Rapacciuolo
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof Antonio Rapacciuolo,MD, PhD
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
137/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.